Literature DB >> 19198663

Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium.

Lynne L Johnson1, Lorraine Schofield, Tammy Donahay, Mark Bouchard, Athena Poppas, Roland Haubner.   

Abstract

OBJECTIVES: Our aim was to image angiogenesis produced by endomyocardial injection of phVEGF165 in a swine model of hibernating myocardium using [123I]Gluco-arginine-glycine-aspartic acid (RGD) targeting the alphavbeta3 integrins.
BACKGROUND: A noninvasive test to monitor the efficacy of therapy inducing angiogenesis is needed. The interaction between extracellular matrix and endothelial cells in sprouting capillaries is effected primarily by alphavbeta3 integrins that bind through RGD motifs.
METHODS: At 21 +/- 4 days, after left circumflex coronary artery ameroid constrictor placement, 8 swine received endomyocardial injection of 1.2 mg phVEGF165 divided into 6 sites and 6 swine received saline (S) using nonfluoroscopic 3-dimensional endocardial mapping system (Noga)-guided delivery. After 20 +/- 6 days, 13 animals were injected with 6.4 +/- 1.7 mCi [123I]Gluco-RGD, 1 VEGF (vascular endothelial growth factor)-injected animal with I-123-labeled peptide control, and all animals with 2.5 +/- 0.4 mCi of Tl-201 and underwent single-photon emission computed tomography imaging. Blood flow and echocardiographic measurements were made at both time points and tissue analyzed for fibrosis and capillary density by lectin staining.
RESULTS: Hibernating myocardium in the ameroid constrictor territory at time of injections was documented by reduced wall thickening compared with remote. Ratio of myocardial blood flow in left circumflex coronary artery/left anterior descending coronary artery territories increased by 15 +/- 11% in the VEGF animals and fell 13 +/- 12% in S-injected (p < 0.01). There was a small increase in wall thickening in constrictor territory after VEGF (8 +/- 17%) while in S-injected animals wall thickening fell by 23 +/- 31% (p = 0.01 vs. VEGF). Lectin staining as percent positive tissue staining for ameroid territory was higher in VEGF-injected compared with S-injected animals (2.5 +/- 1.5% vs. 0.87 +/- 0.52%, p = 0.01). Focal uptake of [123I]Gluco-RGD corresponding to Tl-201 defects was seen in VEGF-injected but not in S-injected animals. [123I]Gluco-RGD uptake in the ameroid territory as percent injected dose correlated with lectin staining (R2 = 0.80, p = 0.002).
CONCLUSIONS: These data suggest that single-photon emission computed tomography imaging of radiolabeled RGD peptides may be a useful noninvasive method to monitor therapy that induces angiogenesis in the heart.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19198663      PMCID: PMC2636715          DOI: 10.1016/j.jcmg.2008.05.002

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  33 in total

1.  A mechanism for modulation of cellular responses to VEGF: activation of the integrins.

Authors:  T V Byzova; C K Goldman; N Pampori; K A Thomas; A Bett; S J Shattil; E F Plow
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

3.  Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve.

Authors:  J A Fallavollita; M Logue; J M Canty
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

4.  Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand.

Authors:  L L Johnson; L Schofield; P Mastrofrancesco; T Donahay; A Farb; B A Khaw
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

5.  Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

Authors:  R Haubner; H J Wester; F Burkhart; R Senekowitsch-Schmidtke; W Weber; S L Goodman; H Kessler; M Schwaiger
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

6.  Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia.

Authors:  P R Vale; D W Losordo; C E Milliken; M Maysky; D D Esakof; J F Symes; J M Isner
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

7.  Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia.

Authors:  P R Vale; D W Losordo; C E Milliken; M C McDonald; L M Gravelin; C M Curry; D D Esakof; M Maysky; J F Symes; J M Isner
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

8.  Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.

Authors:  R A Tio; T Tkebuchava; T H Scheuermann; C Lebherz; M Magner; M Kearny; D D Esakof; J M Isner; J F Symes
Journal:  Hum Gene Ther       Date:  1999-12-10       Impact factor: 5.695

9.  Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.

Authors:  R Haubner; H J Wester; W A Weber; C Mang; S I Ziegler; S L Goodman; R Senekowitsch-Schmidtke; H Kessler; M Schwaiger
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

10.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

View more
  16 in total

1.  PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.

Authors:  Haokao Gao; Lixin Lang; Ning Guo; Feng Cao; Qimeng Quan; Shuo Hu; Dale O Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-25       Impact factor: 9.236

Review 2.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

3.  Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes.

Authors:  Yared Tekabe; Xiaoping Shen; Joane Luma; Drew Weisenberger; Shi Fang Yan; Roland Haubner; Ann Marie Schmidt; Lynne Johnson
Journal:  EJNMMI Res       Date:  2011-06-07       Impact factor: 3.138

Review 4.  Challenges in the translation of cardiovascular cell therapy.

Authors:  Rajesh Gupta; Douglas W Losordo
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

5.  Preclinical SPECT Imaging of Choroidal Neovascularization in Mice Using Integrin-Binding [99mTc]IDA-D-[c(RGDfK)]2.

Authors:  Seong Joon Ahn; Ho-Young Lee; Hye Kyoung Hong; Jae Ho Jung; Ji Hyun Park; Kyu Hyung Park; Sang Eun Kim; Se Joon Woo; Byung Chul Lee
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

Review 6.  Imaging: guiding the clinical translation of cardiac stem cell therapy.

Authors:  Patricia K Nguyen; Feng Lan; Yongming Wang; Joseph C Wu
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

Review 7.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

Review 8.  The year in molecular imaging.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2009-01

Review 9.  Imaging myocardial angiogenesis.

Authors:  Joanna J Wykrzykowska; Timothy D Henry; John R Lesser; Robert S Schwartz
Journal:  Nat Rev Cardiol       Date:  2009-09-08       Impact factor: 32.419

Review 10.  Small-animal SPECT and SPECT/CT: application in cardiovascular research.

Authors:  Reza Golestani; Chao Wu; René A Tio; Clark J Zeebregts; Artiom D Petrov; Freek J Beekman; Rudi A J O Dierckx; Hendrikus H Boersma; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.